DCVC Bio — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
San Diego, US
Board seatJohn Hamer· per SEC Form D · $55.2M raise · filed Mar 2023
MycoWorks produces Reishi, a premium biomaterial made from Fine Mycelium, used as a sustainable leather alternative in furniture, design, and automotive products.
BiotechCircular EconomyNew MaterialsEmeryville, US
Philip Ross(Director)Michael Lindheim(Executive Officer)Matthew Scullin(Executive Officer, Director)
BoardThomas Grotkjaer(Director)
Board seatKiersten Stead· per SEC Form D
Co-investorsDCVC (Data Collective)Hemisphere Ventures LLCWireframe Ventures8VCAgFunderHumboldt+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.